Subjects who the investigator believes that they can and will comply with the requirements of the protocol should be enrolled in the study. 
A male or female aged 61 years or above at the time of the first vaccination. 
Written informed consent obtained from the subject. 
Healthy subjects or subjects with well controlled underlying disease. 

NCT00397215_inc_T1
Person
aged
NCT00397215_inc_T2
Value
61 years or above
NCT00397215_inc_T3
Condition
Healthy
NCT00397215_inc_T4
Condition
underlying disease
NCT00397215_inc_T5
Qualifier
well controlled
NCT00397215_inc_T6
Person
female
NCT00397215_inc_T7
Person
male
NCT00397215_inc_T8
Observation
Written informed consent
NCT00397215_inc_T9
Observation
can and will comply with the requirements of the protocol